Lymphoma Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: LFD3307FB050EN
Market Monitor Global

Abstracts

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control

This report contains market size and forecasts of Lymphoma Therapy in Global, including the following market information:

Global Lymphoma Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lymphoma Therapy market was valued at 16490 million in 2021 and is projected to reach US$ 24300 million by 2028, at a CAGR of 5.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lymphoma Therapy include Roche, CHIPSCREEN, Johnson & Johnson, Abbvie and Celgene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lymphoma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lymphoma Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lymphoma Therapy Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Lymphoma Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lymphoma Therapy Market Segment Percentages, by Application, 2021 (%)

• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma

Global Lymphoma Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lymphoma Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lymphoma Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lymphoma Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• CHIPSCREEN
• Johnson & Johnson
• Abbvie
• Celgene

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lymphoma Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lymphoma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LYMPHOMA THERAPY OVERALL MARKET SIZE

2.1 Global Lymphoma Therapy Market Size: 2021 VS 2028
2.2 Global Lymphoma Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lymphoma Therapy Players in Global Market
3.2 Top Global Lymphoma Therapy Companies Ranked by Revenue
3.3 Global Lymphoma Therapy Revenue by Companies
3.4 Top 3 and Top 5 Lymphoma Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lymphoma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lymphoma Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Lymphoma Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lymphoma Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lymphoma Therapy Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Lymphoma Therapy Revenue & Forecasts
  4.2.1 By Type - Global Lymphoma Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Lymphoma Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Lymphoma Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lymphoma Therapy Market Size, 2021 & 2028
  5.1.2 Hodgkin Lymphoma
  5.1.3 Non-Hodgkin Lymphoma
5.2 By Application - Global Lymphoma Therapy Revenue & Forecasts
  5.2.1 By Application - Global Lymphoma Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Lymphoma Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Lymphoma Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lymphoma Therapy Market Size, 2021 & 2028
6.2 By Region - Global Lymphoma Therapy Revenue & Forecasts
  6.2.1 By Region - Global Lymphoma Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Lymphoma Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Lymphoma Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lymphoma Therapy Revenue, 2017-2028
  6.3.2 US Lymphoma Therapy Market Size, 2017-2028
  6.3.3 Canada Lymphoma Therapy Market Size, 2017-2028
  6.3.4 Mexico Lymphoma Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lymphoma Therapy Revenue, 2017-2028
  6.4.2 Germany Lymphoma Therapy Market Size, 2017-2028
  6.4.3 France Lymphoma Therapy Market Size, 2017-2028
  6.4.4 U.K. Lymphoma Therapy Market Size, 2017-2028
  6.4.5 Italy Lymphoma Therapy Market Size, 2017-2028
  6.4.6 Russia Lymphoma Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Lymphoma Therapy Market Size, 2017-2028
  6.4.8 Benelux Lymphoma Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lymphoma Therapy Revenue, 2017-2028
  6.5.2 China Lymphoma Therapy Market Size, 2017-2028
  6.5.3 Japan Lymphoma Therapy Market Size, 2017-2028
  6.5.4 South Korea Lymphoma Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Lymphoma Therapy Market Size, 2017-2028
  6.5.6 India Lymphoma Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lymphoma Therapy Revenue, 2017-2028
  6.6.2 Brazil Lymphoma Therapy Market Size, 2017-2028
  6.6.3 Argentina Lymphoma Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lymphoma Therapy Revenue, 2017-2028
  6.7.2 Turkey Lymphoma Therapy Market Size, 2017-2028
  6.7.3 Israel Lymphoma Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Lymphoma Therapy Market Size, 2017-2028
  6.7.5 UAE Lymphoma Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Lymphoma Therapy Major Product Offerings
  7.1.4 Roche Lymphoma Therapy Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 CHIPSCREEN
  7.2.1 CHIPSCREEN Corporate Summary
  7.2.2 CHIPSCREEN Business Overview
  7.2.3 CHIPSCREEN Lymphoma Therapy Major Product Offerings
  7.2.4 CHIPSCREEN Lymphoma Therapy Revenue in Global Market (2017-2022)
  7.2.5 CHIPSCREEN Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Lymphoma Therapy Major Product Offerings
  7.3.4 Johnson & Johnson Lymphoma Therapy Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Abbvie
  7.4.1 Abbvie Corporate Summary
  7.4.2 Abbvie Business Overview
  7.4.3 Abbvie Lymphoma Therapy Major Product Offerings
  7.4.4 Abbvie Lymphoma Therapy Revenue in Global Market (2017-2022)
  7.4.5 Abbvie Key News
7.5 Celgene
  7.5.1 Celgene Corporate Summary
  7.5.2 Celgene Business Overview
  7.5.3 Celgene Lymphoma Therapy Major Product Offerings
  7.5.4 Celgene Lymphoma Therapy Revenue in Global Market (2017-2022)
  7.5.5 Celgene Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lymphoma Therapy Market Opportunities & Trends in Global Market
Table 2. Lymphoma Therapy Market Drivers in Global Market
Table 3. Lymphoma Therapy Market Restraints in Global Market
Table 4. Key Players of Lymphoma Therapy in Global Market
Table 5. Top Lymphoma Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lymphoma Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lymphoma Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lymphoma Therapy Product Type
Table 9. List of Global Tier 1 Lymphoma Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lymphoma Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lymphoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lymphoma Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lymphoma Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lymphoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lymphoma Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lymphoma Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lymphoma Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lymphoma Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lymphoma Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lymphoma Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lymphoma Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lymphoma Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lymphoma Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lymphoma Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lymphoma Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lymphoma Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lymphoma Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lymphoma Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lymphoma Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Lymphoma Therapy Product Offerings
Table 32. Roche Lymphoma Therapy Revenue (US$, Mn), (2017-2022)
Table 33. CHIPSCREEN Corporate Summary
Table 34. CHIPSCREEN Lymphoma Therapy Product Offerings
Table 35. CHIPSCREEN Lymphoma Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Lymphoma Therapy Product Offerings
Table 38. Johnson & Johnson Lymphoma Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Abbvie Corporate Summary
Table 40. Abbvie Lymphoma Therapy Product Offerings
Table 41. Abbvie Lymphoma Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Lymphoma Therapy Product Offerings
Table 44. Celgene Lymphoma Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lymphoma Therapy Segment by Type in 2021
Figure 2. Lymphoma Therapy Segment by Application in 2021
Figure 3. Global Lymphoma Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lymphoma Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lymphoma Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lymphoma Therapy Revenue in 2021
Figure 8. By Type - Global Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 12. US Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 24. China Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lymphoma Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lymphoma Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Lymphoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CHIPSCREEN Lymphoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Lymphoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbvie Lymphoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Lymphoma Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)